Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis
CompletedOBSERVATIONAL
Enrollment
40
Participants
Timeline
Start Date
June 8, 2020
Primary Completion Date
November 13, 2024
Study Completion Date
November 14, 2024
Conditions
Rheumatoid Arthritis
Trial Locations (1)
Unknown
Rouen University Hospital, Rouen
All Listed Sponsors
lead
University Hospital, Rouen
OTHER
NCT04343378 - Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter